Moderna's COVID vaccine gets approval in UK for use in kids 6 to 11 years of age
Maddie Meyer/Getty Images News


The U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) approved Moderna's (NASDAQ:MRNA) COVID-19 vaccine Spikevax for use in children 6 years to 11 years of age in Britain.
MHRA Chief Executive June Raine said, "The vaccine is safe and effective in this age group."

MHRA said the approval takes into account the extension to use in children aged 6 to 11 years already approved by the European Medicines Agency on March 2, as the original Britain license for Spikevax in adults was approved by relying on the EU decision.
Spikevax is authorized in children aged 6 to 11 in Northern Ireland under the update by EMA.
"It is for the Joint Committee on Vaccination and Immunisation (JCVI) to advise in due course on whether 6 to 11s should be offered vaccination with the COVID-19 vaccine made by Moderna as part of the deployment programme," added Raine.
Earlier in the day (April 14), the MHRA approved Valneva's (VALN) COVID-19 vaccine for use in people aged 18 to 50 years.